GENE THERAPY VECTOR

 CLINICAL CENTER GENOTYPING CENTER
Information regarding Cystic Fibrosis, the types of research being performed to finds its cure. Learn more about gene therapy, and treatments for Cystic Fibrosis as well as volunteering opportunities.
The Center has many research laboratories dedicated to finding a cure for Cystic Fibrosis. Meet the different lab directors, their lab members and the laboratories particular focus.
A complete list of publications from the Centers lab directors that are related to Cystic Fibrosis.
Apply for open positions at the Cystic Fibrosis Research Development Center.
Visit other websites of organizations and associations affiliated with Cystic Fibrosis.
Letter from the Director addressing the Centers continued plan for the future.
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 
 

 
 

Beth L. Laube

Beth Home|Publications|Lab Members 

 

 

Beth L. Laube

 Associate Professor
The Johns Hopkins University School of Medicine
Department of Pediatrics
Division of Pediatric Pulmonary
Baltimore, MD
600 North Wolfe Street
Baltimore, Maryland 21287-2533
blaube@jhmi.edu 

 

Beth Laube

        
  Publications
 

Laube, B.L., Georgopoulos, A., and Adams, G.K., III. Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients. JAMA 269:2106-2109, 1993.
 

Laube, B.L., Auci, R.M., Shields, D.E., Christiansen, D.H., Lucas, M.K., Fuchs, H.J., Rosenstein, B.J. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis. Am. J. Respir. Crit. Care Med. 153:752-760, 1996.
 
Laube, B.L., Edwards, A. M., Dalby, R.N., Creticos, P. S., Norman, P.S. The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma. J. Allergy Clin. Immunol. 101:475-83, 1998
 

Zanen, P. and Laube, B.L. Targeting the Lungs with Therapeutic Aerosols. In: Bisgaard, H., O’Callaghan, C. and Smaldone, G., eds. Drug Delivery to the Lung: Clinical Aspects. New York, NY. Marcel Dekker, pp. 211-261, 2001.
 

Suman, J., Laube, B.L., Lin, T-C., Guillaume, B., Dalby, R.N. Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition. Pharm. Res. 19:1-6, 2002.
 

Laube, B.L., Karmazyn, Y., Clark, A.R., Newhouse, M. Targeted Aerosol Delivery in Healthy Human Lungs. In: Dalby, R.N., Byron, P.R. and Farr, S.T., eds. Respiratory Drug Delivery IX. Raleigh, N.C. Serentek Press, Inc. pp. 525-527, 2004.
 

Laube, B.L., Geller, D., Lin,T-C., Dalby, R., Diener-West, M., Zeitlin P.L. Positive expiratory pressure changes aerosol deposition in the lungs of patients with cystic fibrosis. Respir. Care 50:1438-1444, 2005.
 

Guo, Y., Laube, B., Dalby, R. The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model. Pharm. Res. 22:1871-1878, 2005.
 

Laube, B.L. The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination. Respir. Care 50:1162-1176, 2005.
 

Laube, B.L., Norman P.S., Wagner, Jr. H.N. and Adams, III, G.K.  The effect of aerosol distribution on airway responsiveness to inhaled methacholine in patients with asthma.  J. Allergy Clin. Immunol. 89:510-518, 1992.
 

Laube, B.L., Chang, D.Y., Blask, A. N., and Rosenstein, B.J.  Radioaerosol assessment of lung improvement in cystic fibrosis patients treated for acute pulmonary exacerbations.  Chest 101:1302-1308, 1992.
 

Publications Next

615 N. Wolfe Street, Baltimore, MD 21205